His primary scientific interests are in Myocardial infarction, Internal medicine, Cardiology, Surgery and Angioplasty. The concepts of his Myocardial infarction study are interwoven with issues in Electrocardiography, Anesthesia, Chest pain and Hazard ratio. His Electrocardiography research integrates issues from ST segment and Infarction.
His Internal medicine study frequently involves adjacent topics like Triage. His Cardiology study incorporates themes from Odds ratio and Confidence interval. His research investigates the link between Surgery and topics such as Tissue plasminogen activator that cross with problems in Plasminogen activator and Fibrinolytic agent.
His primary areas of study are Internal medicine, Myocardial infarction, Cardiology, Surgery and Thrombolysis. His Myocardial infarction research incorporates themes from Electrocardiography, Angioplasty, Emergency medicine and Intensive care medicine. His Emergency medicine research includes elements of Emergency department, Conventional PCI and Medical emergency.
In the subject of general Cardiology, his work in Heart failure, Percutaneous coronary intervention, ST segment and TIMI is often linked to In patient, thereby combining diverse domains of study. His Surgery research is multidisciplinary, relying on both Tissue plasminogen activator, Clinical trial and Angina. The Thrombolysis study combines topics in areas such as Fibrinolysis and Fibrinolytic agent.
Internal medicine, Cardiology, Myocardial infarction, Percutaneous coronary intervention and Conventional PCI are his primary areas of study. W. Douglas Weaver brings together Internal medicine and In patient to produce work in his papers. His research on Cardiology often connects related areas such as Surgery.
His Myocardial infarction study integrates concerns from other disciplines, such as Stroke, Randomized controlled trial and Hazard ratio. His research in Percutaneous coronary intervention intersects with topics in Coronary angiography, Anesthesia and Radiology. His Conventional PCI study combines topics in areas such as Cardiogenic shock, Intensive care medicine, Triage, Emergency medicine and Quality management.
W. Douglas Weaver focuses on Myocardial infarction, Percutaneous coronary intervention, Cardiology, Internal medicine and Conventional PCI. His studies deal with areas such as Relative risk, Randomized controlled trial, Fibrinolytic agent and Emergency medicine as well as Myocardial infarction. When carried out as part of a general Percutaneous coronary intervention research project, his work on Cangrelor is frequently linked to work in In patient, therefore connecting diverse disciplines of study.
Cardiology and Surgery are commonly linked in his work. His study in Hazard ratio, Clinical endpoint, Unstable angina, Angioplasty and Heart failure is carried out as part of his studies in Internal medicine. The study incorporates disciplines such as Psychological intervention, Data quality, Quality management and Intensive care medicine in addition to Conventional PCI.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction)
Thomas J. Ryan;Elliott M. Antman;Neil H. Brooks;Robert M. Califf.
Journal of the American College of Cardiology (1996)
Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction.
Cannon Cp;Gibson Cm;Lambrew Ct;Shoultz Da.
JAMA (2000)
ACC/AHA Guidelines for the Management of Patients With Acute Myocardial Infarction
Thomas J. Ryan;Jeffrey L. Anderson;Elliott M. Antman.
Journal of the American College of Cardiology (1996)
Predictors of 30-Day Mortality in the Era of Reperfusion for Acute Myocardial Infarction Results From an International Trial of 41 021 Patients
Kerry L. Lee;Lynn H. Woodlief;Eric J. Topol;W. Douglas Weaver.
Circulation (1995)
Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology.
Karen P. Alexander;L. Kristin Newby;Christopher P. Cannon;Paul W. Armstrong.
Circulation (2007)
Confirmation of a heart failure epidemic: findings from the Resource Utilization Among Congestive Heart Failure (REACH) study
Peter A McCullough;Edward F Philbin;John A Spertus;Scott Kaatz.
Journal of the American College of Cardiology (2002)
Darapladib for preventing ischemic events in stable coronary heart disease.
Harvey D. White;Claes Held;Ralph Stewart;Elizabeth Tarka.
The New England Journal of Medicine (2014)
Acute coronary care in the elderly, Part I Non-ST-segment-elevation acute coronary syndromes a scientific statement for healthcare professionals from the american heart association council on clinical cardiology
Karen P. Alexander;L. Kristin Newby;Christopher P. Cannon;Paul W. Armstrong.
Circulation (2007)
Oral ximelagatran for secondary prophylaxis after myocardial infarction: the ESTEEM randomised controlled trial
Lars Wallentin;Robert G Wilcox;W Douglas Weaver;Håkan Emanuelsson.
The Lancet (2003)
A randomized trial of transfer for primary angioplasty versus on-site thrombolysis in patients with high-risk myocardial infarction: the Air Primary Angioplasty in Myocardial Infarction study
Cindy L Grines;Donald R Westerhausen;Lorelei L Grines;J.Timothy Hanlon.
Journal of the American College of Cardiology (2002)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Washington
Duke University
Duke University
University of Washington
University of Alberta
Auckland City Hospital
Scripps Research Institute
Stanford University
University of Cincinnati
New York University
Rovira i Virgili University
Chinese University of Hong Kong
Hebrew University of Jerusalem
Xi'an Jiaotong University
University of Granada
University of Las Palmas de Gran Canaria
Tohoku University
University of Siena
University of Queensland
Technical University of Denmark
University of Idaho
University of New England
Oregon Research Institute
University of Cambridge
University of Applied Sciences and Arts Northwestern Switzerland
Utah State University